Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.2M Buy
157,154
+152,061
+2,986% +$38.3M 0.19% 98
2026
Q1
$1.23M Buy
5,093
+3,286
+182% +$889K 0.01% 401
2025
Q4
$535K Buy
+1,807
New +$541K ﹤0.01% 547
2025
Q2
Sell
-2,565
Closed -$638K 791
2025
Q1
$638K Buy
+2,565
New +$627K 0.01% 291
2024
Q4
Sell
-928
Closed -$205K 756
2024
Q3
$205K Sell
928
-2,134
-70% -$418K ﹤0.01% 478
2024
Q2
$530K Buy
+3,062
New +$532K 0.01% 295
2023
Q3
Sell
-2,273
Closed -$304K 240
2023
Q2
$304K Sell
2,273
-1,766
-44% -$228K 0.05% 172
2023
Q1
$529K Buy
4,039
+639
+19% +$85.5K 0.07% 159
2022
Q4
$480K Buy
+3,400
New +$469K 0.07% 171

Other funds holding IBM

Marex Group's IBM Position: Q2 2026 in Review

Marex Group increased its IBM (IBM) stake by 2,986% in Q2 2026, buying an estimated $38.3M and bringing the position to 157,154 shares worth $44.2M. The position accounts for 0.19% of the portfolio, ranked #98.

Marex Group first reported a position in IBM in Q4 2022 and has held it in 9 quarters since. 3,629 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • Marex Group held 157,154 shares of IBM worth $44.2M as of Q2 2026.
  • Marex Group bought 152,061 IBM shares in Q2 2026, an estimated $38.3M.
  • IBM made up 0.19% of Marex Group's portfolio in Q2 2026, its #98 holding.
  • Marex Group first reported a position in IBM in Q4 2022 and has held it in 9 quarters since.
  • 3,629 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.